Zoetis Inc.

Key metrics

Financial performance

Over the last 9 fiscal years Zoetis Inc.'s revenue grew from $4.89B to $9.47B, a compound annual growth rate of 7.6%. Net profit margin expanded from 16.8% to 28.2% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (2,040 filings)

Recent press releases

• - Quarterly Results2026-05-21

  Zoetis to Participate in Upcoming Investor Conferences

• - Quarterly Results2026-05-20

  Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit **Zoetis.com**.

• - Quarterly Results2026-05-07

  **Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis**

• - Quarterly Results2026-04-02

  Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results

• - Quarterly Results2026-03-12

  Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

Similar companies

The largest companies sharing Zoetis Inc.'s SEC industry classification (pharmaceutical preparations).